Medicinal Product Shortages – update – 30 March 2022

Notice type: Advisory

Date: 30/03/2022


Further Information:

The Health Products Regulatory Authority has been notified of a shortage of the following products:

  • Dalmane 30mg Capsules - PA2010/039/002
  • Gaviscon Advance Chewable Tablets - PA0979/011/008
  • Innohep 14,000IU in 0.7ml, Solution for Injection - PA0046/060/011
  • Innohep 16,000IU in 0.8ml, Solution for Injection - PA0046/060/014
  • Methotrexate 5mg/2ml Injection - PA0822/206/001
  • Miochol-E 20mg Powder and Solvent for Instillation Solution for Inraocular use -PA1245/002/001
  • Pabal 100mcg/ml, Solution for Injection - PA1009/021/001
  • Pinamox 500mg hard Capsules - PA0298/010/004
  • Piriton 4mg Tablets - PA0678/080/001
  • Pravastatin Sodium 40mg Tablets - PA0436/046/003
  • Puregon 900IU/1.08ml Solution for Injection - EU/1/96/008/041
  • Skilarence 30mg Gastro Resistant Tablets - EU/1/17/1201/001
  • Tevanate Once Weekly 70mg Tablets - PA0749/016/001


The following shortages have been resolved and supply has resumed to the Irish market:

  • Bactroban 2%w/w Ointment - PA1077/094/001
  • Cozaar 100mg Film Coated Tablets - PA23198/002/003
  • Dalacin T Topical Lotion 10mg/ml Cutaneous Emulsion - PA0822/121/001
  • Dermovate 0.05%w/w Ointment - PA1077/005/002
  • Divigel 0.1%w/w Gel - PA1327/002/001
  • Fybogel Citrus 3.5g Granules - PA0979/009/001
  • Gaviscon Liquid Aniseed Flavour Oral Suspension - PA0979/015/003
  • Inegy 10mg/80mg Tablets - PA23198/024/004
  • Innohep 10,000IU/ml Solution for Injection - PA0046/060/002
  • Losartan/Hydrochlorothiazide Teva 50mg/12.5mg Film Coated Tablets - PA0749/026/001
  • Losartan/Hydrochlorothiazide Teva 100mg/25mg Film Coated Tablets - PA0749/026/002
  • Movymia 20mcg/80mcl Solution for Injection - EU/1/16/1161/001-002
  • Qlaira Film Coated Tablets - PA1410/058/001
  • Ultiva 1mg Powder for Concentrate for Solution for Infusion - PA1691/032/001


Please see the shortages section of the HPRA website for further information.

The HPRA sends weekly updates concerning medicinal product shortages. However, the above webpage will be updated as new information is provided to the HPRA.


« Back